Experimental mRNA melanoma vaccine shows promise in landmark trial
A breakthrough in skin cancer treatment could soon change how doctors prevent melanoma from returning. In a landmark clinical trial, a personalized mRNA cancer vaccine combined with standard immunotherapy significantly lowered the risk of recurrence and disease spread in high-risk patients following surgery. Dr. Tyler Kang, an oncologist with North Bay Health, joined us on Mornings on 2 to discuss what this milestone means for the future of personalized cancer care.
Top Videos
Experimental mRNA melanoma vaccine shows promise in landmark trial
Earthquake swarm strikes South Bay
CHP begins Thanksgiving holiday enforcement
Black Friday deals curbed by tariff-driven costs
Navigating holiday travel as a non-citizen
Laney College to make security upgrades
Officers detain teens with BB gun
Man receives 2 life sentences for brutal beating of "Grandma Huang"
Foster City man arrested in wife's cold case killing
Celebrating Native Culture: Oakland's Intertribal Friendship House
Older drivers' confidence plummets around age 70
Most Watched
Trump-Zelenskyy Oval Office confrontation
Woman sought after kicking dog in Pittsburg
Patient files lawsuit Kaiser Permanente, alleges sexual assault during surgery
Trump marks 30 days in Oval Office | West Coast Wrap
Gas prices climb in California while they fall in other states
Hundreds of NOAA scientists fired
Arrests and guns seized in probe of Oakland carjacking tied to pot dispensaries
Protesters work to disrupt ICE raid | West Coast Wrap
San Jose teen killed by alleged gang members for wearing red
